Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials
mi
from
Austin, TX
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Island Neuro Associates,PC
mi
from
Plainview, NY
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Island Neuro Associates,PC
mi
from
Plainview, NY
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
New England Institute for Clinical Research
mi
from
Stamford, CT
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
New England Institute for Clinical Research
mi
from
Stamford, CT
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
North Seattle Womens Group
mi
from
Seattle, WA
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
North Seattle Womens Group
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Otri-Med Corporation
mi
from
Edgewood, KY
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Otri-Med Corporation
mi
from
Edgewood, KY
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Long Beach
mi
from
Newport Beach, CA
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Long Beach
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Long Beach
mi
from
Los Alamitos, CA
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Long Beach
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Long Beach
mi
from
Encino, CA
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Long Beach
mi
from
Encino, CA
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmasite Research
mi
from
Baltimore, MD
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmasite Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmquest
mi
from
Greensboro, NC
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmquest
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Premiere Research Institute at Palm Beach Neurology
mi
from
West Palm Beach, FL
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Premiere Research Institute at Palm Beach Neurology
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
mi
from
Orlando, FL
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
San Francisco Clinical Research Center
mi
from
San Francisco, CA
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Summit Research Network
mi
from
Portland, OR
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Summit Research Network
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Westside Family Medical Center
mi
from
Kalamazoo, MI
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Westside Family Medical Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Mercy Health Research
mi
from
Saint Louis, MO
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Mercy Health Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
New England Institute for Clinical Research
mi
from
Stamford, CT
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
New England Institute for Clinical Research
mi
from
Stamford, CT
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
University of Chicago, Illinois - SURGICAL CENTER ONLY, NOT AN ENROLLING CENTER
mi
from
Chicago, IL
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
University of Chicago, Illinois - SURGICAL CENTER ONLY, NOT AN ENROLLING CENTER
mi
from
Chicago, IL
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Diamond Headache Clinic
mi
from
Chicago, IL
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Diamond Headache Clinic
mi
from
Chicago, IL
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Robbins Headache Clinic
mi
from
Northbrook, IL
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Robbins Headache Clinic
mi
from
Northbrook, IL
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Norton Neurology Services
mi
from
Louisville, KY
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Norton Neurology Services
mi
from
Louisville, KY
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
New England Regional Headache Center
mi
from
Worcester, MA
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
New England Regional Headache Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Michigan Headache & Neurological Institute
mi
from
Ann Arbor, MI
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Michigan Headache & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Headache Care Center (Springfield)
mi
from
Springfield, MO
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Headache Care Center (Springfield)
mi
from
Springfield, MO
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Nevada Headache Institute
mi
from
Las Vegas, NV
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Nevada Headache Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Dent Neurosciences Research Institute
mi
from
Amherst, NY
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Dent Neurosciences Research Institute
mi
from
Amherst, NY
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Lenox Hill Hospital, The New York Head and Neck Institute - SURGICAL CENTER ONLY, NOT AN ENROLLING CENTER
mi
from
New York, NY
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Lenox Hill Hospital, The New York Head and Neck Institute - SURGICAL CENTER ONLY, NOT AN ENROLLING CENTER
mi
from
New York, NY
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Carolina Headache Institute
mi
from
Durham, NC
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Carolina Headache Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Jefferson Headache Center at Thomas Jefferson University
mi
from
Philadelphia, PA
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Jefferson Headache Center at Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Inova Medical Group Neurology and Headache
mi
from
Falls Church, VA
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Inova Medical Group Neurology and Headache
mi
from
Falls Church, VA
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Mercy Health Research
mi
from
Saint Louis, MO
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Mercy Health Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
Island Neurological Association
mi
from
Plainview, NY
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
Island Neurological Association
mi
from
Plainview, NY
Click here to add this to my saved trials
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated:  12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Status: Enrolling
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Newport Beach, CA
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Palo Alto, CA
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Santa Monica, CA
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials